Idexx Laboratories (IDXX) Total Current Liabilities (2009 - 2026)

Idexx Laboratories' Total Current Liabilities history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 14.4% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (up 14.4% YoY), while the FY2025 annual figure was $1.1 billion, up 7.58% from the prior year.
• Total Current Liabilities was $1.3 billion for Q1 2026 at Idexx Laboratories, up from $1.1 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.3 billion in Q1 2026 to a low of $883.9 million in Q2 2023.
• Historically, Total Current Liabilities has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities surged 87.73% in 2022, then slipped 24.23% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $1.2 billion in 2022, then fell by 23.0% to $951.5 million in 2023, then climbed by 12.23% to $1.1 billion in 2024, then advanced by 7.58% to $1.1 billion in 2025, then advanced by 13.15% to $1.3 billion in 2026.
• The last three Total Current Liabilities figures came in at $1.3 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.